【摘要】 [目的]了解湖北省在经内镜逆行胰胆管造影(endoscopic retrograde cholangiopancreatography, ERCP)术后胰腺炎(post endoscopic retrograde cholangiopancreatography pancreatitis, PEP)方面的预防情况。[方法]于2023年4月对湖北省31家医院56名ERCP内镜医生(受访者)进行线上问卷调查。问卷调查结合了中华医学会消化内镜学会、美国胃肠内镜学会和欧洲胃肠内镜学会关于PEP的具体预防措施。[结果]共回收有效问卷56份，应答率100%。31家常规开展ERCP医院中87.1%为三级甲等医院；48.4%医院每年开展ERCP例数<100例。80.4%的受访者常规使用非甾体消炎药(non-steroidal anti-inflammatory drugs, NSAIDs)来预防PEP,其中74.5%采用的是双氯芳酸钠栓50 mg。51.8%受访者会在导丝反复进入胰管后放置胰管支架。67.9%和53.6%的受访者会在术后使用奥曲肽和快速补液来预防PEP。[结论]湖北省ERCP内镜医生对于使用NSAIDs药物预防PEP接受度较高，对于其他方法的采用还有待加强。更多还原

【Abstract】 [Objective]To investigate the precautionary treatments of Post Endoscopic Retrograde Cholangiopancreatography pancreatitis(PEP)in Hubei province.[Methods]An online questionnaire survey was conducted among 56 ERCP endoscopists in 31 hospitals in Hubei Province from April, 2023.The questionnaire survey was combined with the specific preventive treatments of PEP from Chinese Society of Digestive Endoscopology, American Society of Gastrointestinal Endoscopy and European Society of Gastrointestinal Endoscope.[Results]A total of 56 valid questionnaires were collected, with a response rate of 100%.The 87.1% hospitals who routinely carry out ERCP were tertiary hospital, 51.6% of the hospital carried out ERCP cases less than 100 cases per year.80.4% of the endoscopists routinely used non-steroidal anti-inflammatory drugs(NSAIDs)to prevent PEP,and 74.5% of them used dicloarboxylic acid sodium suppository 50 mg.51.8% of survey respondents placed pancreatic duct stents when the guide wire repeatedly enters the pancreatic duct.67.9% and 53.6% of them used octreotide and rehydration as postoperative treatments to prevent PEP.[Conclusion]NSAIDs drugs are the most common method to prevent PEP,other treatments still need to strengthened.更多还原